Effect of Chemotherapy Followed by GM-CSF for Acute Leukemias at Higher Age or After Relapse

[1]  F. Herrmann,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts. , 1989, Leukemia.

[2]  S. Nimer,et al.  Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor , 1989 .

[3]  J. Gutterman,et al.  Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. , 1988, The New England journal of medicine.

[4]  A. Ganser,et al.  Phase I/II study with GM-CSF in patients with myelodysplastic syndromes. , 1988, Behring Institute Mitteilungen.

[5]  T. MacVittie,et al.  Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. , 1988, Experimental hematology.

[6]  G. Demetri,et al.  In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells. , 1988, Experimental hematology.

[7]  M. Pébusque,et al.  Growth response of human myeloid leukemia cells to colony-stimulating factors. , 1988, Experimental hematology.

[8]  E. Shpall,et al.  RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PRODUCES FEVER , 1988, The Lancet.

[9]  R. Bast,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. , 1988, The New England journal of medicine.

[10]  M. Brizzi,et al.  Induction of proliferation of acute myeloblastic leukemia (AML) cells with hemopoietic growth factors. , 1988, Leukemia research.

[11]  N. Nara,et al.  Effects of recombinant G-CSF and GM-CSF on the growth in methylcellulose and suspension of the blast cells in acute myeloblastic leukemia. , 1988, Leukemia research.

[12]  J. Gutterman,et al.  Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. , 1987, The New England journal of medicine.

[13]  T. MacVittie,et al.  The effect of recombinant GM-CSF on the recovery of monkeys transplanted with autologous bone marrow. , 1987, Blood.

[14]  J. Groopman,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. , 1987, The New England journal of medicine.

[15]  M. Minden,et al.  The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. , 1987, Blood.

[16]  E. Vellenga,et al.  Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. , 1987, Leukemia.

[17]  S. Karlsson,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. , 1987, The Journal of clinical investigation.

[18]  Richard J. Jones,et al.  CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4- hydroperoxycyclophosphamide-purged bone marrow , 1987 .

[19]  E. Liehl,et al.  Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. , 1987, Blood.

[20]  E. Vellenga,et al.  Acute Myeloblastic Leukemia , 1996 .

[21]  B. Powell,et al.  Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias. , 1987, Seminars in oncology.

[22]  R. Gray,et al.  Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trial. , 1987, Seminars in oncology.

[23]  K. Straif,et al.  High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. , 1987, Seminars in oncology.

[24]  H. Preisler,et al.  Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study. , 1987, Blood.

[25]  M. Minden,et al.  Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia. , 1987, Blood.

[26]  W. Hiddemann,et al.  DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes , 1986, Cancer.

[27]  P. Sehgal,et al.  Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF , 1986, Nature.

[28]  W. Hiddemann,et al.  Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  D. Cerretti,et al.  Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Hiddemann,et al.  Differential pattern of DNA-aneuploidy in human malignancies. , 1985, Pathology, research and practice.

[31]  Robert C. Leif,et al.  Convention on nomenclature for DNA cytometry , 1984 .

[32]  C. Begg,et al.  A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. , 1984, Blood.

[33]  N. Nissen,et al.  Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. , 1982, Blood.

[34]  C. Bloomfield,et al.  Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. , 1981, Blood.